Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HRT and dementia.

I Skoog1, D Gustafson

  • 1University of Göteborg, Institute of Clinical Neuroscience, Sahlgrenska University Hospital, Sweden.

Journal of Epidemiology and Biostatistics
|March 1, 2000
PubMed
Summary
This summary is machine-generated.

Oestrogen and hormone replacement therapy (HRT) show potential in preventing Alzheimer's Disease and cognitive decline, particularly in cell and animal models. However, human studies require further investigation due to methodological limitations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders.

Cerebral circulation - cognition and behavior·2024
Same author

Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers.

The journal of prevention of Alzheimer's disease·2024
Same author

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.

Fluids and barriers of the CNS·2023
Same author

Publisher Correction: Brain charts for the human lifespan.

Nature·2022
Same author

Brain charts for the human lifespan.

Nature·2022
Same author

Knowledge about infections is associated with antibiotic use: cross-sectional evidence from the health survey Northern Ireland.

BMC public health·2021
Same journal

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses.

Journal of epidemiology and biostatistics·2002
Same journal

A piecewise-homogeneous Markov chain process of lung transplantation.

Journal of epidemiology and biostatistics·2002
Same journal

Determining and visualising at-risk groups in case-control data.

Journal of epidemiology and biostatistics·2002
Same journal

Distribution of family history of a disease as a function of mode of inheritance, genetic relative hazard, allele frequency and disease status of the proband, with application to female breast cancer.

Journal of epidemiology and biostatistics·2002
Same journal

Changes and trends in attack distributions and progression of dental caries in three age cohorts in Finland.

Journal of epidemiology and biostatistics·2002
Same journal

A loss-function based approach for dose selection in two-stage dose-response trials.

Journal of epidemiology and biostatistics·2002
See all related articles

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • The role of oestrogens and hormone replacement therapy (HRT) in neurodegenerative diseases like Alzheimer's Disease (AD) and vascular dementia remains unclear.
  • Research spans cell, animal, and human studies to elucidate these complex relationships.

Purpose of the Study:

  • To review existing data on the effects of oestrogens on dementia and cognitive decline.
  • To evaluate the hypothesis that oestrogen use reduces dementia risk in various experimental models.

Main Methods:

  • Literature search using keywords: oestrogen and dementia, oestrogen and Alzheimer, oestrogen and cognition, oestrogen and learning, oestrogen and memory.
  • Examination of reference lists from identified articles.

Related Experiment Videos

Main Results:

  • Cell and animal studies provide the strongest evidence, suggesting oestrogens may impact AD pathogenesis by influencing beta-amyloid metabolism, cholinergic activity, oxidative stress, and cardiovascular risk.
  • Observational studies hint at a protective effect of HRT against cognitive decline in the elderly, but possess inherent methodological limitations.
  • Clinical trials investigating HRT and cognitive decline have methodological issues preventing definitive conclusions.

Conclusions:

  • Oestrogen's beneficial effects on cognitive function and dementia prevention are most strongly supported by preclinical (cell and animal) data.
  • While observational studies suggest a potential protective role for HRT, robust clinical trial evidence is lacking due to methodological constraints.